Overview

Growth Hormone in the Treatment of HIV-Associated Wasting

Status:
Completed
Trial end date:
2002-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare physical function and lean body mass in patients getting different doses of somatropin compared to patients not getting the drug.
Phase:
Phase 3
Details
Lead Sponsor:
EMD Serono
Treatments:
Hormones